Some biomedical applications of ferrofluids

Ferrofluids are colloidal solutions of iron oxide magnetic nanoparticles in either a polar or no polar liquid. We present here two biological applications using maghemite (γFe 2 O 3 ) ferrofluids: magnetic cell sorting and magnetocytolysis. The first application employs magnetic particles binding a biological effector, which is capable to recognize the target cells specifically. These cells become magnetic and can be sorted in a gradient of magnetic field. We describe first the various steps of the synthesis of a biocompatible ferrofluid and the grafting an effector protein onto the particles. We then describe the use of particles carrying annexin V in the separation and quantification of damaged erythrocytes in blood samples. This very sensitive technique can be used to follow the erythrocytes ageing of normal blood samples during their storage under blood bank conditions or to detect the membrane modifications that are associated with some pathologies such as malaria or Alzheimer's disease. The dependence of the magnetic susceptibility versus the frequency is a way to transform magnetic energy into thermal energy. Magnetocytolysis is the destruction of cells, carrying magnetic particles, through the action of an alternating magnetic field (about 1 MHz). We present here preliminary experiments with macrophages, which demonstrate the method's feasibility and the formation of the non-specific interactions between the cells and the magnetic particles.

[1]  D. Hall,et al.  Immobilization of Anabaena azollae in hallow fibre photobioreactors for ammonia production , 1991 .

[2]  J. Bacri,et al.  Use of Magnetic Nanoparticles for Thermolysis of Cells in a Ferrofluid , 1997 .

[3]  S. Singer,et al.  Iron-dextran antibody conjugates: General method for simultaneous staining of two components in high-resolution immunoelectron microscopy. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P F Renshaw,et al.  Ferromagnetic contrast agents: A new approach , 1986, Magnetic resonance in medicine.

[5]  V A Namiot,et al.  Magnetoliposomes: another principle of cell sorting. , 1983, Biochimica et biophysica acta.

[6]  A. Bée,et al.  Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid , 1997, Journal of colloid and interface science.

[7]  Annexin V binding to mouse erythrocytes following infection with Plasmodium parasites. , 1996, Parasitology today.

[8]  B. Fertil,et al.  Membrane modifications of red blood cells in Alzheimer's disease. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  A. Bée,et al.  Adsorption of gluconic and citric acids on maghemite particles in aqueous medium , 1996 .

[10]  Klaus Mosbach,et al.  Magnetic biospecific affinity adsorbents for immunoglobulin and enzyme isolation , 1981, Applied biochemistry and biotechnology.

[11]  V. Cabuil,et al.  Synthèse en milieu alcalin de magnétite colloïdale : contrôle du rendement et de la taille des particules , 1987 .

[12]  J. Bacri,et al.  Magnetic Maghemite Nanoparticles , 1997 .

[13]  J. Bacri,et al.  Biomedical applications of maghemite ferrofluid. , 1998, Biochimie.

[14]  R. Molday,et al.  Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. , 1982, Journal of immunological methods.

[15]  J. Bacri,et al.  Quantification of Maghemite Nanoparticles in Biological Media by Ferromagnetic Resonance and Its Alteration by Conjugation with Biological Substances , 1997 .